Timothy G. Rodgers

Timothy Rodgers practices at Rodgers Dermatology in Frisco, Texas.

Timothy Rodgers' NPI, 1255395067, was assigned on April 17, 2006. Timothy Rodgers graduated from Feinberg School of Medicine in 2002. Timothy Rodgers holds Texas license M2776.

Timothy Rodgers' primary practice is Rodgers Dermatology, at 3880 Parkwood Blvd Suite 102 Suite 102, Frisco, TX 75034-1928. The practice phone is (972) 704-2400.

Timothy Rodgers' primary practice is Rodgers Dermatology in Frisco, Texas. The medical group on file is Rodgers Dermatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Timothy Rodgers practices. Vendor and product names are available with a free account.

Dermatology is Timothy Rodgers' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Timothy Rodgers is board certified in dermatology by the American Board of Dermatology. Dmand AI has Timothy Rodgers' licenses on file in 3 states: Texas, Michigan and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Timothy Rodgers treats.

CMS data shows 3,316 Medicare services from Timothy Rodgers across 19 procedure codes in 2024, for 703 Medicare patients. Medicare paid $142,667 for them. Every service was in an office.

CMS counts 703 Medicare patients who saw Timothy Rodgers in 2024. The largest group is 65 to 74, with 368 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Timothy Rodgers' median patient age at 54, with 51% women.

In 2024, Timothy Rodgers wrote 438 Medicare Part D claims for 220 patients. 98% of them were for generic drugs. CMS names the drug for 301 of them, across 7 drugs with 11 or more claims each, at $6,236 in total drug cost. In 2023, CMS named 288 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Timothy Rodgers for performance year 2024, reported individually. Timothy Rodgers accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,099 procedures of removal of skin lesions by Timothy Rodgers, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Timothy Rodgers.

Dmand AI links Timothy Rodgers to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Dermatitis, Atopic, Psoriasis and Skin Diseases, Eczematous. Nektar Therapeutics sponsors the most, 2. Open Payments lists research payments to Timothy Rodgers that name 2 trials.

CMS Open Payments shows 672 general payments to Timothy Rodgers from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Abbvie Inc. paid the most, $2,131. It also lists 8 research payments totaling $23,316 from 2019 to 2023, naming 2 clinical trials.

Dmand AI lists 1 award for Timothy Rodgers.

Timothy Rodgers graduated from Feinberg School of Medicine in 2002. Timothy Rodgers is a member of AAD.

Timothy Rodgers is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.